Buprenorphine versus methadone maintenance for the treatment of opioid dependence

Addiction

Volumn 94, Issue 9, 1999, Pages 1337-1347

  Fischer, Gabriele ^a   Gombas, Wolfgang ^b   Eder, Harald ^b   Jagsch, Reinhold ^b   Peternell, Alexandra ^b   Stühlinger, Georg ^b   Pezawas, Lukas ^b   Aschauer, Harald N ^b   Kasper, Siegfried ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; COCAINE; METHADONE; OPIATE;

ADULT; ARTICLE; AUSTRIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; OUTPATIENT DEPARTMENT; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; URINALYSIS;

EID: 0032877350     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1999.94913376.x     Document Type: Article

References (42)

1. AJIR, K., LING, W. & CHIANG, N. (1998) Pharmacokineties of liquid versus tablet buprenorphine, Book of Abstracts, College on Problems of Drug Dependence, 2.
2. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (Washington, DC, American Psychiatric Association).
3. BICKEL, W. K., AMASS, L., CREAN, J. P. & HIGGINS, S. T. (1995) Triple buprenorphine maintenance doses maintain opioid-dependent outpatients for 72 hours with minimal withdrawal, NIDA Research Monograph 153, 161.
4. BICKEL, W. R., STTTZER, M. L., BIGELOW, G. E., LIEBSON, I. A., JASINSKI, D. R. & JOHNSON, R. E. (1988) A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts, Clinical Pharmacology and Experimental Therapeutics, 43, 72-78.
5. BORTZ, J. (1989) Statistics for Social Sciences (Berlin, Springer).
6. BULLINGHAM, R. E. S., McQUAY, H. J., PORTER, E. J. B., ALLEN, M. C. & MOORE, R. A. (1982) Sublingual buprenorphine used postoperatively: ten hours plasma drug concentration analysis, British Journal of Clinical Pharmacology, 1, 665-673.
7. DAWSON-SAUNDERS, B. & TRAPP, R. G. (1990) Basic and Clinical Biostatistics (East Norwalk, CT, Appleton & Lange).
8. DIAMANT, K., FISCHER, G., SCHNEIDER, C. et al. (1998) Out-patient opiate detoxification treatment with buprenorphine, European Addiction Research, 4, 198-202.
9. DOLE, V. P. & NYSWANDER, M. (1965) A medical treatment for diacetylmorphine (heroin) addiction, Journal of the American Medical Association, 193, 80-84.
10. EMIT® ASSAY TROUBLESHOOTING GUIDE (1983) Syva Co., Palo Alto, CA.
11. FISCHER, G., PRESSLICH, O., DIAMANT, K., SCHNEIDER, C., PEZAWAS, L. & KASPER, S. (1996) Oral morphine-sulphate in the treatment of opiate dependent subjects, Alcoholism, 32, 35-43.
12. FISCHER, G., EDER, H., JAGSCH, R. et al. (1998) Maintenance therapy with synthetic opioids within a multidisciplinary program - a stabilizing necessity for pregnant opioid dependent females, Archives of Women's Mental Health, 1, 109-116.
13. FISCHER, G., JAGSCH, R., EDER, H. et al. (1999) Comparison of methadone and slow-release morphine maintenance in pregnant addicts, Addiction 94, 231-239.
14. GONZALEZ, J. & BRODGEN, R. (1992) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence, Drugs, 180, 734-735.
15. JASINSKI, D. R., PEVNIK, J. S. & GRIFFITH, J. D. (1978) Human pharmacology and abuse potential of the analgesic buprenorphine, Archives of General Psychiatry, 35, 501-506.
16. JOHNSON, R. E., CONE, E. J., HENNINGFIELD, J. E. & FUDALA, P. J. (1989) Use of buprenorphine in the treatment of opiate addiction. I. Psychologic and behavioural effects during a rapid dose induction, Pharmacological Therapy, 46, 335-343.
17. JOHNSON, R. E., JAFFE, J. H. & FUDALA, P. J. (1992) A controlled trial of buprenorphine treatment for opioid dependence, Journal of the American Medical Association, 267, 2750-2755.
18. KAPLAN, E. L., & MEIER, P. (1958) Non-parametric estimation from incomplete observations, Journal of the American Statistical Association, 53, 471-481.
19. KOLAR, A. F., BROWN, B. S., WEDDINGTON, W. W. & BALL, J. C. (1990) A treatment crisis: cocaine use by clients in methadone maintenance programs, Journal of Substance Abuse Treatment, 7, 101-107.
20. KOSTEN, T. R., KLEBER, H. D. & MORGAN, C. H. (1989) Treatment of cocaine abuse with buprenorphine, Biological Psychiatry, 26, 637-639.
21. KOSTEN, T. H., SCHOTTENFELD, R., ZIEDONIS, D. & FALCONI, J. (1993) Buprenorphine versus methadone maintenance for opioid dependence, Journal of Nervous and Mental Diseases, 181, 358-364.
22. KOURI, E. M., LUKAS, S. E. & MENDELSON, J. H. (1996) P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment, Biological Psychiatry, 40, 617-628.
23. LANGE, W. R., FUDALA, P. J., DAX, E. M. & JOHNSON, R. E. (1990) Safety and side effects of buprenorphine in the clinical management of heroin addiction, Drug and Alcohol Dependence, 26, 19-28.
24. LAW, F. D., BAILEY, J. E., ALLEN, D. S. et al. (1997) The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting, Addiction Biology, 2, 191-200.
25. LING, W., RAWSON, R. A. & COMPTON, M. A., (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine, Journal of Psychoactive Drugs, 26, 119-128.
26. LING, W., WESSON, D. R., CHARUVASTRA, C. & KLETT, C. J. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence, Archives of General Psychiatry, 53, 401-407.
27. LING, W., CHARUVASTRA, C., COLLINS, J. et al. (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial, Addiction, 93, 475-586.
28. MELLO, N. K., MENDELSON, J. H., BREE, M. P. & LUKAS, S. E. (1989) Buprenorphine suppresses cocaine self-administration by rhesus monkeys, Science, 245, 859-862.
29. McLELLAN, A. T., LUBORSKY, L., O'BRIAN, C. P. & WOODY, G. E. (1980) An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index, Journal of Nervous and Mental Disease, 168, 26-33.
30. MORIKAWA, T. & YOSHIDA, M. (1995) A useful testing strategy in phase III trials and test of equivalence, Journal of Biopharmaceutical Statistics, 5, 297-306.
31. NEWMAN, R. G. (1987) Methadone treatment, New England Journal of Medicine, 317, 447-450.
32. NORUSIS, M. J. (1994) SPSS. Advanced Statistics 6.1. (Chicago, SPSS Inc.).
33. O'BRIEN, C. P. (1994) Overview: the treatment of drug dependence, Addiction, 89, 1565-1569.
34. PATRICIO, L. D. & MIGUEL, N. (1997) Role of LAAM, methadone and naltrexone in the care of opiate dependence: experience in Portugal, Annals of Internal Medicine, 145, 28-30.
35. PLOMP, H. N., VAN DER HEK, H. & ADER, H. J. (1996) The Amsterdam methadone dispensing circuit: genesis and effectiveness of a public health model for local drug politics, Addiction, 91, 711-721.
36. SCHOENBAUM, H. & SELWYN, P. A. (1995) Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use, American Journal of Public Health, 85, 83-88.
37. SCHOTTENFELD, R. S. & KLEBER, H. D. (1995) Methadone maintenance, in: KAPLAN, H. I. & SADOCK, B. J. (Eds) Comprehensive Textbook of Psychiatry, pp. 2031-2038 (Baltimore Williams & Wilkins).
38. SCHOTTENFELD, R. S., PAKES, J. R., OLIVIETO, A., ZIEDONIS, D. & KOSTEN, T. (1997) Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse, Archives of General Psychiatry, 54, 713-720.
39. SCHOTTENFELD, R. S., PAKES, J. R. & KOSTEN, T. (1998) Prognostic factors in buprenorphine versus methadone maintained patients, Journal of Nervous and Mental Disease, 186, 1, 35-43.
40. STARIN, E. C., STITZER, M. L., LIEBSON, I. A. & BIGELOW, G. E. (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence, American Journal of Psychiatry, 15, 1025-1030.
41. WALTER, D. S., CHAPLEO, C. B. & REISINGER, M. (1996) Discussion Forum, in: REISINGER, M. (Ed.) European Forum on Buprenorphine: a new substitution agent for the treatment of opioid addiction, Research and Clinical Forums, 19, 39-46.
42. VOCCI, F., CHIANG, C. N., CUMMINGS, L. & HAWKS, R. (1995) Overview: medications development for the treatment of drug abuse, NIDA Research Monograph, 149, 4-15.